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Abstract
Calcineurin has been implicated as part of a critical signaling pathway for learning and memory,
and recent data suggest that calcineurin activation mediates some of the neurotoxicity of the
Alzheimer related neurotoxin Aβ. Immunosuppression via calcineurin inhibition with the
compound FK506 is an important treatment for organ transplant patients. Here we use Golgi
impregnation techniques, along with a new survival analysis-based statistical approach for analysis
of dendritic complexity, to show that in healthy adult mice one week of treatment with FK506
affects both the branching patterns and dendritic spine density of cortical neurons. These results
indicate that calcineurin inhibition leads to readily detectable changes in brain morphology, further
implicating calcineurin related pathways in both the function and structure of the adult brain.
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Introduction
Calcineurin has been long established as a critical mediator of cellular pathways underlying
both electrophysiologic and behavioural measures of learning and memory, likely through
mechanisms involving dephosphorylation of spine associated proteins as well as activation
of specific transcriptional pathways [3,5–7,11,12,17,21,23]. Upregulation of calcineurin
activity has also been implicated in Alzheimer disease models, where it is believed to be
important for amyloid-beta induced loss of glutamate receptors and dendritic spine loss
[2,16,27,31]. Inhibition of calcineurin has accordingly been shown to enhance memory
performance in some paradigms in normal rodents, as well as in APP overexpressing
Alzheimer models [8,20–22,32]. To better understand the underlying neurobiology of these
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effects, we asked whether short term inhibition of calcineurin would impact brain structure
in normal adult animals.
The calcineurin inhibitor FK506 (tacrolimus), is an inhibitor that acts via the complex of
FK506 and FK506-binding protein binding to calcineurin to prevent calcineurin-mediated
dephosphorylation [25]. FK506 is a commonly used immunosuppressant to combat graft
versus host disease after transplant surgery [1]; however, serious neurological side effects
occur in over 10% of FK506 treated patients including tremor, aphasia, cortical blindness,
hallucinations, and memory impairment [19,30], underlying the need to clarify the effects of
FK506 on healthy brain. FK506 (tacrolimus) is administered long-term after transplantation,
but neurological side effects can manifest within days [10], thus we examined acute effects
of systemic administration of FK506 on the brain.
Materials and Methods
Non-transgenic mice from Jackson laboratories (B6C3F1/J mice 6–8 months of age) were
group housed in standard rodent cages with ad libitum access to water and mouse chow. A
bolus of 0.1 mL/ 10g of mouse of 10mg/mL FK506 (Sigma Aldrich, St. Louis, MO -
dissolved in 10% ethanol with 1% tween 80 in PBS [4], or vehicle (10% ethanol with 1%
tween 80 in PBS without drug) was administered i.p. daily for 7 days (n=4 animals FK506, 4
animals vehicle treated).
After FK506 or vehicle treatment, mice were euthanized, perfused with PBS followed by
10% formalin, and post-fixed for 48 hours. All animals were sacrificed in one session (2
hours) to prevent variability in spine density due to the time of day. Brains were shipped to
Neurostructural Research Labs (Tampa, FL) for rapid Golgi impregnation and sectioning to
120 µm. Layer II-III cortical neurons (located throughout the cortex) were sampled and
analyzed for spine density and dendritic branching using Nikon Photobot and camera lucida.
To analyze the dendritic branching, a Scholl analysis using concentric circles spaced 10
microns apart was used. To analyze spine density, dendrite segments from apical branches
(n=83 dendrites from 4 FK506 treated animals, 85 from 4 vehicle treated animals) and basal
dendrites (n=105 dendrites from 4 FK506 treated animals, 100 dendrites from 4 vehicle
treated animals) were traced in fine detail including spines; the number of spines per neurite
segment counted, and the image was scanned and the length of the dendrite measured using
NIH software Image J to calculate linear spine density. Photomicrographs of dendritic spines
were obtained on an Olympus BX51 microscope mounted with a DP70 camera and contrast
enhanced in Adobe Photoshop.
To analyze the complexity of the dendritic tree from the Sholl plot data, we developed an
algorithm using a survival analysis technique with follow-up “time” as the longest distance
(from the cell body of a neuron) reached by each dendritic tree. The administrative
censoring was set at the distance of 240µm from the soma. We considered two different
events of interest: distance to zero intersections of dendrites with the concentric circles
drawn around the soma and distance to one intersection. Due to the nature of the experiment,
there were few “censored” (i.e., not observed all the way to 0 intersections) observations: 4
for distance to zero intersection and 3 for distance to one intersection. We tested the
appropriate contrasts among the coefficients in the model to assess the effects of treatment.
For spine analyses, normality of data was confirmed using a Shapiro-Wilkes test. 1-way
ANOVAs were used to asses the effects of treatment. These data are presented as means and
standard deviations from the mean.
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Results
To investigate the effects of calcineurin inhibition with FK506 on neuronal morphology,
mice were treated for 1 week with daily i.p. injections of 0.1 mL/ 10g of mouse of 10mg/mL
FK506, a dose known from previous rodent studies to achieve a brain level of FK506 of
~300 ng/gm tissue for at least 72 hours after the injection [4]. Mice were sacrificed after 7
days of i.p. injections and brains extracted for Golgi impregnation.
Golgi-impregnated layer II-III neurons from treated and untreated mice were traced using
camera lucida. A total of 71 cells from 4 FK506 treated animals and 100 cells from 4 vehicle
treated animals were traced (representative cells shown in figure 1A). Sholl plot analysis
(Figure 1B, C) shows an increase in complexity of the basal dendritic tree of layer II–III
neurons with FK506 treatment in wild-type mouse cortex. The treatment has a significant
impact on the overall dendritic arbor (p-value=0.0104 and p-value = 0.0079 respectively for
distance to zero and distance to one intersection). Those treated with FK506 have longer
total dendritic arbor and more complex branching further away from the cell body compared
to untreated animals.
Dendritic spines are known to be affected in many neurological disorders [9]. Basal and
apical dendrites of layer II–II neurons differ in their inputs (basal and proximal apical
dendrites receive excitatory inputs from layer IV neurons and local layer II–III neurons
while more distal apical tufts receive inputs from thalamus and other cortical areas) and their
distinct morphologies suggest that inputs to basal and apical dendrites might be integrated
differently [28]. Thus we examined the dendritic spines along both apical and basal
dendrites. We examined spines in FK506 and vehicle treated animals (basal dendrites n=105
dendrites from 4 FK506 treated animals, 100 dendrites from 4 vehicle treated animals;
apical dendrites n=83 dendrites from 4 FK506 treated animals, 85 from 4 vehicle treated
animals). We observed an increase in basal dendritic spine density (ANOVA
F[1,204]=11.8132, p=0.0007) concomitant with the increased dendritic branching seen with
Sholl plots.
Discussion
Dendrites integrate synaptic inputs to neurons, and their branching is thought to be related to
their representational capacity [24]. Branching patterns of dendritic trees are related to the
degree of compartmentalization of inputs to the cell and a stronger potential for
compartmentalization (i.e. more complex branching) has been proposed to increase the
representational power of the cell resulting in greater learning and memory capacity. [24]
Dendritic structure appears to be regulated during development in part by calcineurin [26].
Dendritic spines, which comprise the post synaptic element of over 90% of cortical
excitatory synapses, are thought to be particularly important for learning and memory [18].
Calcineurin activation has been implicated in the changes of dendritic spine morphology
associated with long term depression [33]. Changes in dendritic spines and in dendritic
branching are associated with many neurological disorders, underlying their importance in
brain connectivity [9].
We investigated the effects of one week of systemic calcineurin inhibition using FK506
treatment on wild-type mouse neocortex to test the hypothesis that calcineurin affects
neuroplasticity mechanisms, dendritic remodeling, and dendritic spines in the adult cortex
using classical Golgi impregnation techniques, combined with a new statistical approach to
analyze Sholl plot analyses of dendritic complexity based on survival analysis.
We observe a marked increase (15%) in basal dendritic spine density and an increase in the
complexity of basal dendritic trees of neurons in animals treated with systemic calcineurin
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inhibition for only one week. Our new analysis method for branching data gives an
indication of the complexity of the entire arbor instead of comparing mean numbers of
intersections at individual distances from the soma with t-tests as is often seen in the
literature [15].
These data are in accord with our recent observations that introduction of a constitutively
active form of calcineurin into neurons in the adult cortex (via AAV mediated gene transfer)
had the opposite effect: decrease in dendritic spines and diminution of dendritic arbor
complexity [31]. Both of these effects – of spine loss after exposure to calcineurin activation
and of spine increases after exposure to calcineurin inhibition – are of substantially greater
magnitude than expected for week to week changes in adult cortex, in which only minor
changes in spine density occur and dendritic arborizations (of pyramidal neurons) remain
unchanged over several months of observation in vivo [13,14,29].
These results suggest that alterations in calcineurin dramatically impact the morphology of
dendritic systems, thereby potentially altering neural system efficiency and responses, even
in the adult brain. The data suggest a rather larger degree of plasticity in both dendritic spine
number and in dendritic arborization patterns than perhaps would have been expected in
non-pathological conditions in the adult brain, since dendritic trees and dendritic spines are
stable over long periods of imaging in vivo as mentioned above. It is possible that these
structural changes in dendrites underlie both the improved memory performance seen in
some paradigms after calcineurin inhibition, as well as potentially some of the observed
neurological side effects in patients treated with FK506.
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Figure 1.
Golgi-impregnated layer II–III cortical neurons were traced using camera lucida in FK506
and vehicle treated animals (A). A series of concentric circles every 10 µm (B) was used for
Sholl analysis. Quantification (C) shows an increase in branching of basal dendrites with
FK506 treatment, which is significant using our survival analysis method. Error bars
represent standard deviation from the mean.
Spires-Jones et al. Page 7
Neurosci Lett. Author manuscript; available in PMC 2012 January 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Dendritic spines were examined on basal and apical dendrites of layer II–III pyramidal
neurons (A). FK506 treatment increased spine density along basal dendrites (B)Scale bar
represents 10 µm. Error bars represent standard deviation from the mean.
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